These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30971808)

  • 1. Identification of SAMD9L as a susceptibility locus for intravenous immunoglobulin resistance in Kawasaki disease by genome-wide association analysis.
    Kim JJ; Yun SW; Yu JJ; Yoon KL; Lee KY; Kil HR; Kim GB; Han MK; Song MS; Lee HD; Ha KS; Sohn S; Ebata R; Hamada H; Suzuki H; Ito K; Onouchi Y; Hong YM; Jang GY; Lee JK;
    Pharmacogenomics J; 2020 Feb; 20(1):80-86. PubMed ID: 30971808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the IL16 Asn1147Lys polymorphism with intravenous immunoglobulin resistance in Kawasaki disease.
    Kim HJ; Kim JJ; Yun SW; Yu JJ; Yoon KL; Lee KY; Kil HR; Kim GB; Han MK; Song MS; Lee HD; Ha KS; Hong YM; Jang GY; Lee JK;
    J Hum Genet; 2020 Apr; 65(4):421-426. PubMed ID: 31965063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease.
    Amano Y; Akazawa Y; Yasuda J; Yoshino K; Kojima K; Kobayashi N; Matsuzaki S; Nagasaki M; Kawai Y; Minegishi N; Ishida N; Motoki N; Hachiya A; Nakazawa Y; Yamamoto M; Koike K; Takeshita T
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):34. PubMed ID: 31269967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction for Intravenous Immunoglobulin Resistance by Using Weighted Genetic Risk Score Identified From Genome-Wide Association Study in Kawasaki Disease.
    Kuo HC; Wong HS; Chang WP; Chen BK; Wu MS; Yang KD; Hsieh KS; Hsu YW; Liu SF; Liu X; Chang WC
    Circ Cardiovasc Genet; 2017 Oct; 10(5):e001625. PubMed ID: 29025760
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Uittenbogaard P; Netea SA; Tanck MWT; Geissler J; Buda P; Kowalczyk-Domagała M; Okarska-Napierała M; van Stijn D; Tacke CE; ; Burgner DP; Shimizu C; Burns JC; Kuipers IM; Kuijpers TW; Nagelkerke SQ
    Front Immunol; 2024; 15():1323171. PubMed ID: 39359734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease.
    Tang B; Lo HH; Lei C; U KI; Hsiao WW; Guo X; Bai J; Wong VK; Law BY
    Phytomedicine; 2020 Apr; 70():153208. PubMed ID: 32283413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array.
    Kuo HC; Chang JC; Kuo HC; Yu HR; Wang CL; Lee CP; Huang LT; Yang KD
    Arthritis Rheumatol; 2015 Mar; 67(3):828-36. PubMed ID: 25470559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CCR2-CCR5 haplotypes and CCL3L1 copy number with Kawasaki Disease, coronary artery lesions, and IVIG responses in Japanese children.
    Mamtani M; Matsubara T; Shimizu C; Furukawa S; Akagi T; Onouchi Y; Hata A; Fujino A; He W; Ahuja SK; Burns JC
    PLoS One; 2010 Jul; 5(7):e11458. PubMed ID: 20628649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in the number of CCL3L1 gene copies and Kawasaki disease in Korean children.
    Kim HE; Kim JJ; Han MK; Lee KY; Song MS; Lee HD; Kim DS; Yu JJ; Park IS; Yun SW; Hong YM; Jang GY; Lee JK;
    Pediatr Cardiol; 2012 Dec; 33(8):1259-63. PubMed ID: 22450355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki disease.
    Kim JJ; Yun SW; Yu JJ; Yoon KL; Lee KY; Kil HR; Kim GB; Han MK; Song MS; Lee HD; Ha KS; Sohn S; Johnson TA; Takahashi A; Kubo M; Tsunoda T; Ito K; Onouchi Y; Hong YM; Jang GY; Lee JK;
    J Hum Genet; 2017 Dec; 62(12):1023-1029. PubMed ID: 28855716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGB1 gene polymorphism is associated with coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
    Ahn JG; Bae Y; Shin D; Nam J; Kim KY; Kim DS
    Rheumatology (Oxford); 2019 May; 58(5):770-775. PubMed ID: 30535242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease.
    Zhang RL; Lo HH; Lei C; Ip N; Chen J; Law BY
    Curr Opin Pharmacol; 2020 Oct; 54():72-81. PubMed ID: 32956895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease.
    Kim JJ; Hong YM; Sohn S; Jang GY; Ha KS; Yun SW; Han MK; Lee KY; Song MS; Lee HD; Kim DS; Lee JE; Shin ES; Jang JH; Lee YS; Kim SY; Lee JY; Han BG; Wu JY; Kim KJ; Park YM; Seo EJ; Park IS; Lee JK;
    Hum Genet; 2011 May; 129(5):487-95. PubMed ID: 21221998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease.
    Onouchi Y; Suzuki Y; Suzuki H; Terai M; Yasukawa K; Hamada H; Suenaga T; Honda T; Honda A; Kobayashi H; Takeuchi T; Yoshikawa N; Sato J; Shibuta S; Miyawaki M; Oishi K; Yamaga H; Aoyagi N; Iwahashi S; Miyashita R; Murata Y; Ebata R; Higashi K; Ozaki K; Sasago K; Tanaka T; Hata A
    Pharmacogenomics J; 2013 Feb; 13(1):52-9. PubMed ID: 21987091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
    Chang LS; Lo MH; Li SC; Yang MY; Hsieh KS; Kuo HC
    Oncotarget; 2017 Jan; 8(2):2044-2052. PubMed ID: 27893416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin, pharmacogenomics, and Kawasaki disease.
    Kuo HC; Hsu YW; Wu MS; Chien SC; Liu SF; Chang WC
    J Microbiol Immunol Infect; 2016 Feb; 49(1):1-7. PubMed ID: 25556045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density genotyping of immune loci in Kawasaki disease and IVIG treatment response in European-American case-parent trio study.
    Shendre A; Wiener HW; Zhi D; Vazquez AI; Portman MA; Shrestha S
    Genes Immun; 2014 Dec; 15(8):534-42. PubMed ID: 25101798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between P2RY12 Gene Polymorphisms and IVIG Resistance in Kawasaki Patients.
    Wang Z; Xu Y; Zhou H; Wang Y; Li W; Lu Z; Jiang Z; Gu X; Zheng H; Zeng L; Huang P; Zhang L; Gu X
    Cardiovasc Ther; 2020; 2020():3568608. PubMed ID: 32256707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of risk factors for Korean children with Kawasaki disease.
    Kim JJ; Hong YM; Yun SW; Han MK; Lee KY; Song MS; Lee HD; Kim DS; Sohn S; Ha KS; Hong SJ; Kim KJ; Park IS; Jang GY; Lee JK;
    Pediatr Cardiol; 2012 Apr; 33(4):513-20. PubMed ID: 22105492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of activating FcγR gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response.
    Shrestha S; Wiener H; Shendre A; Kaslow RA; Wu J; Olson A; Bowles NE; Patel H; Edberg JC; Portman MA
    Circ Cardiovasc Genet; 2012 Jun; 5(3):309-16. PubMed ID: 22565545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.